Annual Net Income
-$116.66 M
-$6.44 M-5.84%
31 December 2023
Summary:
Tonix Pharmaceuticals Holding annual net profit is currently -$116.66 million, with the most recent change of -$6.44 million (-5.84%) on 31 December 2023. During the last 3 years, it has fallen by -$66.19 million (-131.18%). TNXP annual net income is now -552781.52% below its all-time high of -$21.10 thousand, reached on 31 December 2008.TNXP Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Net Income
-$14.21 M
+$64.56 M+81.96%
30 September 2024
Summary:
Tonix Pharmaceuticals Holding quarterly net profit is currently -$14.21 million, with the most recent change of +$64.56 million (+81.96%) on 30 September 2024. Over the past year, it has increased by +$13.76 million (+49.19%). TNXP quarterly net income is now -2866.79% below its all-time high of $513.70 thousand, reached on 31 March 2011.TNXP Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Net Income
-$135.25 M
+$13.76 M+9.24%
30 September 2024
Summary:
Tonix Pharmaceuticals Holding TTM net profit is currently -$135.25 million, with the most recent change of +$13.76 million (+9.24%) on 30 September 2024. Over the past year, it has dropped by -$14.23 million (-11.76%). TNXP TTM net income is now -1502677.78% below its all-time high of -$9000.00, reached on 31 March 2008.TNXP TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TNXP Net Income Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -5.8% | +49.2% | -11.8% |
3 y3 years | -131.2% | +23.3% | -69.6% |
5 y5 years | -347.1% | -81.3% | -391.8% |
TNXP Net Income High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3 years | -131.2% | at low | at high | +82.0% | -69.6% | +9.2% |
5 y | 5 years | -347.1% | at low | -95.4% | +82.0% | -391.8% | +9.2% |
alltime | all time | <-9999.0% | at low | -2866.8% | +82.0% | <-9999.0% | +9.2% |
Tonix Pharmaceuticals Holding Net Income History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2024 | - | -$14.21 M(-82.0%) | -$135.25 M(-9.2%) |
June 2024 | - | -$78.78 M(+427.3%) | -$149.01 M(+51.1%) |
Mar 2024 | - | -$14.94 M(-45.3%) | -$98.59 M(-15.5%) |
Dec 2023 | -$116.66 M(+5.8%) | -$27.32 M(-2.3%) | -$116.66 M(-3.6%) |
Sept 2023 | - | -$27.98 M(-1.3%) | -$121.02 M(-0.8%) |
June 2023 | - | -$28.36 M(-14.1%) | -$122.02 M(+4.5%) |
Mar 2023 | - | -$33.01 M(+4.2%) | -$116.81 M(+6.0%) |
Dec 2022 | -$110.22 M(+19.4%) | -$31.68 M(+9.3%) | -$110.22 M(+2.0%) |
Sept 2022 | - | -$28.98 M(+25.2%) | -$108.09 M(+10.7%) |
June 2022 | - | -$23.14 M(-12.4%) | -$97.64 M(-0.4%) |
Mar 2022 | - | -$26.42 M(-10.6%) | -$98.05 M(+6.2%) |
Dec 2021 | -$92.29 M(+82.9%) | -$29.55 M(+59.5%) | -$92.29 M(+15.7%) |
Sept 2021 | - | -$18.53 M(-21.3%) | -$79.75 M(+8.9%) |
June 2021 | - | -$23.55 M(+14.0%) | -$73.22 M(+14.7%) |
Mar 2021 | - | -$20.65 M(+21.3%) | -$63.84 M(+26.5%) |
Dec 2020 | -$50.46 M(+76.3%) | -$17.02 M(+42.0%) | -$50.46 M(+19.7%) |
Sept 2020 | - | -$11.99 M(-15.4%) | -$42.15 M(+10.9%) |
June 2020 | - | -$14.18 M(+95.0%) | -$38.00 M(+28.1%) |
Mar 2020 | - | -$7.27 M(-16.5%) | -$29.66 M(+3.6%) |
Dec 2019 | -$28.62 M(+9.7%) | -$8.71 M(+11.1%) | -$28.62 M(+4.1%) |
Sept 2019 | - | -$7.84 M(+34.2%) | -$27.50 M(+9.4%) |
June 2019 | - | -$5.84 M(-6.3%) | -$25.14 M(-1.0%) |
Mar 2019 | - | -$6.23 M(-17.9%) | -$25.39 M(-2.7%) |
Dec 2018 | -$26.09 M(+23.5%) | -$7.59 M(+38.5%) | -$26.09 M(+8.7%) |
Sept 2018 | - | -$5.48 M(-10.0%) | -$23.99 M(-1.3%) |
June 2018 | - | -$6.09 M(-12.2%) | -$24.30 M(+5.7%) |
Mar 2018 | - | -$6.93 M(+26.3%) | -$22.99 M(+8.9%) |
Dec 2017 | -$21.12 M(-45.6%) | -$5.49 M(-5.1%) | -$21.12 M(-8.6%) |
Sept 2017 | - | -$5.79 M(+21.0%) | -$23.11 M(-7.2%) |
June 2017 | - | -$4.78 M(-5.6%) | -$24.90 M(-16.8%) |
Mar 2017 | - | -$5.06 M(-32.3%) | -$29.93 M(-22.9%) |
Dec 2016 | -$38.84 M | -$7.48 M(-1.3%) | -$38.84 M(-13.1%) |
Sept 2016 | - | -$7.58 M(-22.7%) | -$44.72 M(-11.3%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
June 2016 | - | -$9.81 M(-29.8%) | -$50.39 M(-3.7%) |
Mar 2016 | - | -$13.98 M(+4.6%) | -$52.35 M(+8.9%) |
Dec 2015 | -$48.05 M(+74.0%) | -$13.36 M(+0.8%) | -$48.05 M(+10.0%) |
Sept 2015 | - | -$13.25 M(+12.6%) | -$43.68 M(+15.4%) |
June 2015 | - | -$11.76 M(+21.5%) | -$37.85 M(+17.8%) |
Mar 2015 | - | -$9.68 M(+7.7%) | -$32.13 M(+16.4%) |
Dec 2014 | -$27.62 M(+153.7%) | -$8.99 M(+21.2%) | -$27.62 M(+23.7%) |
Sept 2014 | - | -$7.42 M(+22.7%) | -$22.33 M(+24.0%) |
June 2014 | - | -$6.04 M(+17.0%) | -$18.00 M(+28.2%) |
Mar 2014 | - | -$5.16 M(+39.3%) | -$14.05 M(+29.1%) |
Dec 2013 | -$10.88 M(+15.2%) | -$3.71 M(+20.0%) | -$10.88 M(+11.0%) |
Sept 2013 | - | -$3.09 M(+48.1%) | -$9.81 M(+16.1%) |
June 2013 | - | -$2.09 M(+4.2%) | -$8.45 M(-10.5%) |
Mar 2013 | - | -$2.00 M(-23.9%) | -$9.44 M(-0.1%) |
Dec 2012 | -$9.45 M(+172.3%) | -$2.63 M(+51.8%) | -$9.45 M(+12.4%) |
Sept 2012 | - | -$1.73 M(-43.7%) | -$8.41 M(+9.3%) |
June 2012 | - | -$3.07 M(+52.5%) | -$7.69 M(+54.7%) |
Mar 2012 | - | -$2.02 M(+27.0%) | -$4.97 M(+103.5%) |
Dec 2011 | -$3.47 M(+76.6%) | -$1.59 M(+56.4%) | -$2.44 M(-13.0%) |
Sept 2011 | - | -$1.01 M(+185.1%) | -$2.81 M(+56.2%) |
June 2011 | - | -$355.80 K(-169.3%) | -$1.80 M(+24.5%) |
Mar 2011 | - | $513.70 K(-126.3%) | -$1.45 M(-26.4%) |
Dec 2010 | -$1.96 M(+6257.6%) | -$1.95 M(>+9900.0%) | -$1.96 M(>+9900.0%) |
Sept 2010 | - | -$3700.00(+54.2%) | -$15.40 K(+7.7%) |
June 2010 | - | -$2400.00(-58.6%) | -$14.30 K(-44.6%) |
Mar 2010 | - | -$5800.00(+65.7%) | -$25.80 K(-16.5%) |
Dec 2009 | -$30.90 K(+46.4%) | -$3500.00(+34.6%) | -$30.90 K(+1.3%) |
Sept 2009 | - | -$2600.00(-81.3%) | -$30.50 K(-3.5%) |
June 2009 | - | -$13.90 K(+27.5%) | -$31.60 K(+37.4%) |
Mar 2009 | - | -$10.90 K(+251.6%) | -$23.00 K(+9.0%) |
Dec 2008 | -$21.10 K | -$3100.00(-16.2%) | -$21.10 K(+17.2%) |
Sept 2008 | - | -$3700.00(-30.2%) | -$18.00 K(+25.9%) |
June 2008 | - | -$5300.00(-41.1%) | -$14.30 K(+58.9%) |
Mar 2008 | - | -$9000.00 | -$9000.00 |
FAQ
- What is Tonix Pharmaceuticals Holding annual net profit?
- What is the all time high annual net income for Tonix Pharmaceuticals Holding?
- What is Tonix Pharmaceuticals Holding annual net income year-on-year change?
- What is Tonix Pharmaceuticals Holding quarterly net profit?
- What is the all time high quarterly net income for Tonix Pharmaceuticals Holding?
- What is Tonix Pharmaceuticals Holding quarterly net income year-on-year change?
- What is Tonix Pharmaceuticals Holding TTM net profit?
- What is the all time high TTM net income for Tonix Pharmaceuticals Holding?
- What is Tonix Pharmaceuticals Holding TTM net income year-on-year change?
What is Tonix Pharmaceuticals Holding annual net profit?
The current annual net income of TNXP is -$116.66 M
What is the all time high annual net income for Tonix Pharmaceuticals Holding?
Tonix Pharmaceuticals Holding all-time high annual net profit is -$21.10 K
What is Tonix Pharmaceuticals Holding annual net income year-on-year change?
Over the past year, TNXP annual net profit has changed by -$6.44 M (-5.84%)
What is Tonix Pharmaceuticals Holding quarterly net profit?
The current quarterly net income of TNXP is -$14.21 M
What is the all time high quarterly net income for Tonix Pharmaceuticals Holding?
Tonix Pharmaceuticals Holding all-time high quarterly net profit is $513.70 K
What is Tonix Pharmaceuticals Holding quarterly net income year-on-year change?
Over the past year, TNXP quarterly net profit has changed by +$13.76 M (+49.19%)
What is Tonix Pharmaceuticals Holding TTM net profit?
The current TTM net income of TNXP is -$135.25 M
What is the all time high TTM net income for Tonix Pharmaceuticals Holding?
Tonix Pharmaceuticals Holding all-time high TTM net profit is -$9000.00
What is Tonix Pharmaceuticals Holding TTM net income year-on-year change?
Over the past year, TNXP TTM net profit has changed by -$14.23 M (-11.76%)